nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimethoprim—CYP3A4—Temozolomide—malignant glioma	0.208	1	CbGbCtD
Trimethoprim—Abnormal behaviour—Temozolomide—malignant glioma	0.0189	0.0522	CcSEcCtD
Trimethoprim—Lung infiltration—Carmustine—malignant glioma	0.0155	0.0429	CcSEcCtD
Trimethoprim—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00744	0.0206	CcSEcCtD
Trimethoprim—Aplastic anaemia—Temozolomide—malignant glioma	0.00661	0.0183	CcSEcCtD
Trimethoprim—Vascular purpura—Temozolomide—malignant glioma	0.00571	0.0158	CcSEcCtD
Trimethoprim—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00542	0.015	CcSEcCtD
Trimethoprim—Hyponatraemia—Carmustine—malignant glioma	0.00531	0.0147	CcSEcCtD
Trimethoprim—Purpura—Temozolomide—malignant glioma	0.0053	0.0147	CcSEcCtD
Trimethoprim—Ataxia—Carmustine—malignant glioma	0.00497	0.0137	CcSEcCtD
Trimethoprim—Ataxia—Temozolomide—malignant glioma	0.0048	0.0133	CcSEcCtD
Trimethoprim—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.0046	0.0127	CcSEcCtD
Trimethoprim—Pancytopenia—Carmustine—malignant glioma	0.00434	0.012	CcSEcCtD
Trimethoprim—Neutropenia—Carmustine—malignant glioma	0.00427	0.0118	CcSEcCtD
Trimethoprim—Pancytopenia—Temozolomide—malignant glioma	0.00419	0.0116	CcSEcCtD
Trimethoprim—Neutropenia—Temozolomide—malignant glioma	0.00413	0.0114	CcSEcCtD
Trimethoprim—Pneumonia—Carmustine—malignant glioma	0.0041	0.0113	CcSEcCtD
Trimethoprim—Depression—Carmustine—malignant glioma	0.00406	0.0112	CcSEcCtD
Trimethoprim—Photosensitivity reaction—Temozolomide—malignant glioma	0.00403	0.0111	CcSEcCtD
Trimethoprim—Renal failure—Carmustine—malignant glioma	0.00401	0.0111	CcSEcCtD
Trimethoprim—Neuropathy peripheral—Carmustine—malignant glioma	0.00399	0.011	CcSEcCtD
Trimethoprim—Stomatitis—Carmustine—malignant glioma	0.00397	0.011	CcSEcCtD
Trimethoprim—Pneumonia—Temozolomide—malignant glioma	0.00396	0.0109	CcSEcCtD
Trimethoprim—Infestation NOS—Temozolomide—malignant glioma	0.00394	0.0109	CcSEcCtD
Trimethoprim—Infestation—Temozolomide—malignant glioma	0.00394	0.0109	CcSEcCtD
Trimethoprim—Depression—Temozolomide—malignant glioma	0.00393	0.0109	CcSEcCtD
Trimethoprim—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.0039	0.0108	CcSEcCtD
Trimethoprim—Neuropathy peripheral—Temozolomide—malignant glioma	0.00386	0.0107	CcSEcCtD
Trimethoprim—Stomatitis—Temozolomide—malignant glioma	0.00384	0.0106	CcSEcCtD
Trimethoprim—Hepatobiliary disease—Temozolomide—malignant glioma	0.00372	0.0103	CcSEcCtD
Trimethoprim—Hallucination—Carmustine—malignant glioma	0.00364	0.0101	CcSEcCtD
Trimethoprim—Connective tissue disorder—Carmustine—malignant glioma	0.00359	0.00993	CcSEcCtD
Trimethoprim—Hallucination—Temozolomide—malignant glioma	0.00352	0.00972	CcSEcCtD
Trimethoprim—Urinary tract disorder—Temozolomide—malignant glioma	0.00349	0.00965	CcSEcCtD
Trimethoprim—Connective tissue disorder—Temozolomide—malignant glioma	0.00347	0.0096	CcSEcCtD
Trimethoprim—Urethral disorder—Temozolomide—malignant glioma	0.00347	0.00958	CcSEcCtD
Trimethoprim—Eye disorder—Carmustine—malignant glioma	0.00342	0.00945	CcSEcCtD
Trimethoprim—Erythema multiforme—Temozolomide—malignant glioma	0.00334	0.00924	CcSEcCtD
Trimethoprim—Eye disorder—Temozolomide—malignant glioma	0.0033	0.00913	CcSEcCtD
Trimethoprim—Tinnitus—Temozolomide—malignant glioma	0.0033	0.00911	CcSEcCtD
Trimethoprim—Mental disorder—Carmustine—malignant glioma	0.0032	0.00886	CcSEcCtD
Trimethoprim—Immune system disorder—Temozolomide—malignant glioma	0.00319	0.00882	CcSEcCtD
Trimethoprim—Mediastinal disorder—Temozolomide—malignant glioma	0.00319	0.0088	CcSEcCtD
Trimethoprim—Erythema—Carmustine—malignant glioma	0.00318	0.0088	CcSEcCtD
Trimethoprim—Malnutrition—Carmustine—malignant glioma	0.00318	0.0088	CcSEcCtD
Trimethoprim—Mental disorder—Temozolomide—malignant glioma	0.0031	0.00856	CcSEcCtD
Trimethoprim—Malnutrition—Temozolomide—malignant glioma	0.00308	0.0085	CcSEcCtD
Trimethoprim—Erythema—Temozolomide—malignant glioma	0.00308	0.0085	CcSEcCtD
Trimethoprim—Tremor—Carmustine—malignant glioma	0.00298	0.00824	CcSEcCtD
Trimethoprim—Agitation—Carmustine—malignant glioma	0.00293	0.00809	CcSEcCtD
Trimethoprim—Tremor—Temozolomide—malignant glioma	0.00288	0.00797	CcSEcCtD
Trimethoprim—DHFR—embryo—malignant glioma	0.00285	0.0945	CbGeAlD
Trimethoprim—Leukopenia—Carmustine—malignant glioma	0.00285	0.00788	CcSEcCtD
Trimethoprim—Agitation—Temozolomide—malignant glioma	0.00283	0.00782	CcSEcCtD
Trimethoprim—Angioedema—Temozolomide—malignant glioma	0.00281	0.00777	CcSEcCtD
Trimethoprim—Vertigo—Temozolomide—malignant glioma	0.00276	0.00764	CcSEcCtD
Trimethoprim—Convulsion—Carmustine—malignant glioma	0.00276	0.00762	CcSEcCtD
Trimethoprim—Leukopenia—Temozolomide—malignant glioma	0.00275	0.00761	CcSEcCtD
Trimethoprim—Myalgia—Carmustine—malignant glioma	0.00271	0.00749	CcSEcCtD
Trimethoprim—Anxiety—Carmustine—malignant glioma	0.0027	0.00747	CcSEcCtD
Trimethoprim—Cough—Temozolomide—malignant glioma	0.00269	0.00742	CcSEcCtD
Trimethoprim—Convulsion—Temozolomide—malignant glioma	0.00267	0.00737	CcSEcCtD
Trimethoprim—Confusional state—Carmustine—malignant glioma	0.00262	0.00724	CcSEcCtD
Trimethoprim—Arthralgia—Temozolomide—malignant glioma	0.00262	0.00724	CcSEcCtD
Trimethoprim—Myalgia—Temozolomide—malignant glioma	0.00262	0.00724	CcSEcCtD
Trimethoprim—Anxiety—Temozolomide—malignant glioma	0.00261	0.00722	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.0026	0.00719	CcSEcCtD
Trimethoprim—Thrombocytopenia—Carmustine—malignant glioma	0.00254	0.00703	CcSEcCtD
Trimethoprim—Confusional state—Temozolomide—malignant glioma	0.00253	0.007	CcSEcCtD
Trimethoprim—DHFR—retina—malignant glioma	0.00252	0.0835	CbGeAlD
Trimethoprim—Anaphylactic shock—Temozolomide—malignant glioma	0.00251	0.00694	CcSEcCtD
Trimethoprim—Anorexia—Carmustine—malignant glioma	0.00248	0.00685	CcSEcCtD
Trimethoprim—Nervous system disorder—Temozolomide—malignant glioma	0.00246	0.00681	CcSEcCtD
Trimethoprim—Thrombocytopenia—Temozolomide—malignant glioma	0.00246	0.0068	CcSEcCtD
Trimethoprim—Skin disorder—Temozolomide—malignant glioma	0.00244	0.00674	CcSEcCtD
Trimethoprim—Anorexia—Temozolomide—malignant glioma	0.00239	0.00662	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00237	0.00654	CcSEcCtD
Trimethoprim—Insomnia—Carmustine—malignant glioma	0.00235	0.0065	CcSEcCtD
Trimethoprim—TYMS—telencephalon—malignant glioma	0.00234	0.0776	CbGeAlD
Trimethoprim—DHFR—telencephalon—malignant glioma	0.00232	0.0768	CbGeAlD
Trimethoprim—Dyspnoea—Carmustine—malignant glioma	0.00232	0.0064	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00229	0.00632	CcSEcCtD
Trimethoprim—Insomnia—Temozolomide—malignant glioma	0.00227	0.00628	CcSEcCtD
Trimethoprim—Decreased appetite—Carmustine—malignant glioma	0.00226	0.00624	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Carmustine—malignant glioma	0.00224	0.0062	CcSEcCtD
Trimethoprim—Dyspnoea—Temozolomide—malignant glioma	0.00224	0.00619	CcSEcCtD
Trimethoprim—Constipation—Carmustine—malignant glioma	0.00222	0.00614	CcSEcCtD
Trimethoprim—Dyspepsia—Temozolomide—malignant glioma	0.00221	0.00611	CcSEcCtD
Trimethoprim—Decreased appetite—Temozolomide—malignant glioma	0.00218	0.00603	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00217	0.00599	CcSEcCtD
Trimethoprim—Constipation—Temozolomide—malignant glioma	0.00215	0.00594	CcSEcCtD
Trimethoprim—Feeling abnormal—Carmustine—malignant glioma	0.00214	0.00592	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Carmustine—malignant glioma	0.00213	0.00587	CcSEcCtD
Trimethoprim—Feeling abnormal—Temozolomide—malignant glioma	0.00207	0.00572	CcSEcCtD
Trimethoprim—Abdominal pain—Carmustine—malignant glioma	0.00205	0.00568	CcSEcCtD
Trimethoprim—Body temperature increased—Carmustine—malignant glioma	0.00205	0.00568	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Temozolomide—malignant glioma	0.00205	0.00568	CcSEcCtD
Trimethoprim—Urticaria—Temozolomide—malignant glioma	0.002	0.00551	CcSEcCtD
Trimethoprim—Body temperature increased—Temozolomide—malignant glioma	0.00199	0.00549	CcSEcCtD
Trimethoprim—Abdominal pain—Temozolomide—malignant glioma	0.00199	0.00549	CcSEcCtD
Trimethoprim—Hypersensitivity—Carmustine—malignant glioma	0.00191	0.00529	CcSEcCtD
Trimethoprim—Hypersensitivity—Temozolomide—malignant glioma	0.00185	0.00511	CcSEcCtD
Trimethoprim—DHFR—medulla oblongata—malignant glioma	0.00182	0.0604	CbGeAlD
Trimethoprim—Diarrhoea—Carmustine—malignant glioma	0.00178	0.00491	CcSEcCtD
Trimethoprim—Pruritus—Temozolomide—malignant glioma	0.00178	0.00491	CcSEcCtD
Trimethoprim—Dizziness—Carmustine—malignant glioma	0.00172	0.00475	CcSEcCtD
Trimethoprim—Diarrhoea—Temozolomide—malignant glioma	0.00172	0.00475	CcSEcCtD
Trimethoprim—TYMS—midbrain—malignant glioma	0.00168	0.0557	CbGeAlD
Trimethoprim—DHFR—midbrain—malignant glioma	0.00167	0.0552	CbGeAlD
Trimethoprim—Dizziness—Temozolomide—malignant glioma	0.00166	0.00459	CcSEcCtD
Trimethoprim—Vomiting—Carmustine—malignant glioma	0.00165	0.00457	CcSEcCtD
Trimethoprim—Rash—Carmustine—malignant glioma	0.00164	0.00453	CcSEcCtD
Trimethoprim—Dermatitis—Carmustine—malignant glioma	0.00164	0.00452	CcSEcCtD
Trimethoprim—Headache—Carmustine—malignant glioma	0.00163	0.0045	CcSEcCtD
Trimethoprim—DHFR—spinal cord—malignant glioma	0.00163	0.0538	CbGeAlD
Trimethoprim—Vomiting—Temozolomide—malignant glioma	0.0016	0.00441	CcSEcCtD
Trimethoprim—Rash—Temozolomide—malignant glioma	0.00158	0.00438	CcSEcCtD
Trimethoprim—Dermatitis—Temozolomide—malignant glioma	0.00158	0.00437	CcSEcCtD
Trimethoprim—Headache—Temozolomide—malignant glioma	0.00157	0.00435	CcSEcCtD
Trimethoprim—Nausea—Carmustine—malignant glioma	0.00154	0.00427	CcSEcCtD
Trimethoprim—Nausea—Temozolomide—malignant glioma	0.00149	0.00412	CcSEcCtD
Trimethoprim—TYMS—central nervous system—malignant glioma	0.00133	0.0441	CbGeAlD
Trimethoprim—DHFR—central nervous system—malignant glioma	0.00132	0.0437	CbGeAlD
Trimethoprim—TYMS—cerebellum—malignant glioma	0.0013	0.0431	CbGeAlD
Trimethoprim—DHFR—cerebellum—malignant glioma	0.00129	0.0427	CbGeAlD
Trimethoprim—ABCB1—blood vessel—malignant glioma	0.00114	0.0377	CbGeAlD
Trimethoprim—TYMS—brain—malignant glioma	0.00106	0.035	CbGeAlD
Trimethoprim—DHFR—brain—malignant glioma	0.00105	0.0347	CbGeAlD
Trimethoprim—ABCB1—embryo—malignant glioma	0.000679	0.0225	CbGeAlD
Trimethoprim—ABCB1—retina—malignant glioma	0.0006	0.0199	CbGeAlD
Trimethoprim—ABCB1—telencephalon—malignant glioma	0.000552	0.0183	CbGeAlD
Trimethoprim—CYP2C8—brain—malignant glioma	0.00052	0.0172	CbGeAlD
Trimethoprim—CYP3A4—central nervous system—malignant glioma	0.000444	0.0147	CbGeAlD
Trimethoprim—ABCB1—medulla oblongata—malignant glioma	0.000434	0.0144	CbGeAlD
Trimethoprim—ABCB1—midbrain—malignant glioma	0.000397	0.0131	CbGeAlD
Trimethoprim—ABCB1—spinal cord—malignant glioma	0.000387	0.0128	CbGeAlD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.000319	0.000796	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—APOD—malignant glioma	0.000318	0.000794	CbGpPWpGaD
Trimethoprim—DHFR—Disease—JAG1—malignant glioma	0.000315	0.000789	CbGpPWpGaD
Trimethoprim—ABCB1—central nervous system—malignant glioma	0.000314	0.0104	CbGeAlD
Trimethoprim—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000313	0.000783	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.000313	0.000783	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—RTEL1—malignant glioma	0.000311	0.000778	CbGpPWpGaD
Trimethoprim—DHFR—Disease—FBXW7—malignant glioma	0.000309	0.000773	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—CXCL8—malignant glioma	0.000309	0.000771	CbGpPWpGaD
Trimethoprim—CYP2C9—Biological oxidations—GSTP1—malignant glioma	0.000308	0.00077	CbGpPWpGaD
Trimethoprim—ABCB1—cerebellum—malignant glioma	0.000307	0.0102	CbGeAlD
Trimethoprim—CYP2C9—Metapathway biotransformation—GSTP1—malignant glioma	0.000304	0.000759	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.000303	0.000757	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—GSTT1—malignant glioma	0.000302	0.000755	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—CDKN2A—malignant glioma	0.000302	0.000755	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.000296	0.00074	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—IL1B—malignant glioma	0.000296	0.00074	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—CASP3—malignant glioma	0.000295	0.000738	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—IL2—malignant glioma	0.000295	0.000737	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.000294	0.000734	CbGpPWpGaD
Trimethoprim—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000293	0.000732	CbGpPWpGaD
Trimethoprim—TYMS—Circadian rythm related genes—TP53—malignant glioma	0.000291	0.000727	CbGpPWpGaD
Trimethoprim—ABCB1—HIF-1-alpha transcription factor network—VEGFA—malignant glioma	0.000289	0.000723	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PTGS1—malignant glioma	0.000283	0.000707	CbGpPWpGaD
Trimethoprim—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000275	0.000686	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000273	0.000683	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—CDKN2A—malignant glioma	0.00027	0.000675	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.000267	0.000667	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000265	0.000661	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—GSTT1—malignant glioma	0.000264	0.000659	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—CDKN2A—malignant glioma	0.000263	0.000659	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—BCHE—malignant glioma	0.000263	0.000658	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—MDM2—malignant glioma	0.000262	0.000655	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—SLC5A5—malignant glioma	0.00026	0.00065	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	0.000256	0.000639	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—VEGFA—malignant glioma	0.000251	0.000626	CbGpPWpGaD
Trimethoprim—ABCB1—brain—malignant glioma	0.000249	0.00825	CbGeAlD
Trimethoprim—TYMS—Metabolism—PTGS1—malignant glioma	0.000247	0.000617	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CDKN2B—malignant glioma	0.000242	0.000605	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.000238	0.000596	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—CDKN2A—malignant glioma	0.000236	0.000589	CbGpPWpGaD
Trimethoprim—DHFR—Disease—HES1—malignant glioma	0.000231	0.000578	CbGpPWpGaD
Trimethoprim—DHFR—Disease—NCOR1—malignant glioma	0.00023	0.000574	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—BCHE—malignant glioma	0.00023	0.000574	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—MDM2—malignant glioma	0.000228	0.000571	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—SLC5A5—malignant glioma	0.000227	0.000567	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000222	0.000556	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PDGFRA—malignant glioma	0.00022	0.00055	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—COX8A—malignant glioma	0.00022	0.000549	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000215	0.000538	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—TNF—malignant glioma	0.000215	0.000537	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.000214	0.000534	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—GSTP1—malignant glioma	0.000209	0.000523	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.000207	0.000517	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000205	0.000513	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—MYC—malignant glioma	0.000205	0.000511	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.000204	0.000511	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—CAT—malignant glioma	0.000204	0.000509	CbGpPWpGaD
Trimethoprim—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.000203	0.000508	CbGpPWpGaD
Trimethoprim—DHFR—Disease—TERT—malignant glioma	0.000202	0.000506	CbGpPWpGaD
Trimethoprim—DHFR—Disease—HLA-A—malignant glioma	0.000202	0.000506	CbGpPWpGaD
Trimethoprim—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.0002	0.000501	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PDGFB—malignant glioma	0.000198	0.000494	CbGpPWpGaD
Trimethoprim—DHFR—Disease—FGFR1—malignant glioma	0.000197	0.000491	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000196	0.000491	CbGpPWpGaD
Trimethoprim—DHFR—Disease—HIF1A—malignant glioma	0.000194	0.000484	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—NCOR1—malignant glioma	0.000192	0.000481	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—COX8A—malignant glioma	0.000191	0.000478	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CAV1—malignant glioma	0.000187	0.000468	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ASMT—malignant glioma	0.000187	0.000467	CbGpPWpGaD
Trimethoprim—ABCB1—HIF-1-alpha transcription factor network—AKT1—malignant glioma	0.000185	0.000462	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—MYC—malignant glioma	0.000183	0.000457	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—GSTP1—malignant glioma	0.000183	0.000457	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000183	0.000456	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—COX8A—malignant glioma	0.000179	0.000447	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—MYC—malignant glioma	0.000179	0.000446	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—CAT—malignant glioma	0.000178	0.000444	CbGpPWpGaD
Trimethoprim—DHFR—Disease—BAD—malignant glioma	0.000176	0.00044	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—BCAN—malignant glioma	0.000176	0.000439	CbGpPWpGaD
Trimethoprim—DHFR—Disease—NOTCH1—malignant glioma	0.000174	0.000436	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.000174	0.000435	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CD80—malignant glioma	0.000171	0.000427	CbGpPWpGaD
Trimethoprim—DHFR—Disease—APC—malignant glioma	0.000171	0.000426	CbGpPWpGaD
Trimethoprim—DHFR—Disease—EGF—malignant glioma	0.000169	0.000421	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—NCOR1—malignant glioma	0.000168	0.00042	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PTPN11—malignant glioma	0.000168	0.000419	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.000165	0.000413	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.000163	0.000407	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ASMT—malignant glioma	0.000163	0.000407	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000163	0.000407	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.000162	0.000406	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.000161	0.000401	CbGpPWpGaD
Trimethoprim—DHFR—Disease—BRAF—malignant glioma	0.00016	0.000401	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.00016	0.0004	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—MYC—malignant glioma	0.00016	0.000399	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.000157	0.000392	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—CAV1—malignant glioma	0.000157	0.000392	CbGpPWpGaD
Trimethoprim—DHFR—Disease—AKT2—malignant glioma	0.000156	0.00039	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—BCAN—malignant glioma	0.000153	0.000382	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ASMT—malignant glioma	0.000152	0.00038	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—TP53—malignant glioma	0.00015	0.000376	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PIK3CD—malignant glioma	0.00015	0.000375	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000149	0.000373	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000149	0.000371	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.000146	0.000364	CbGpPWpGaD
Trimethoprim—DHFR—Disease—FGF2—malignant glioma	0.000144	0.000359	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—BCAN—malignant glioma	0.000143	0.000357	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PIK3CG—malignant glioma	0.000143	0.000357	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000142	0.000355	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—IDH2—malignant glioma	0.000142	0.000354	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PPARG—malignant glioma	0.000138	0.000345	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.000137	0.000342	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—CAV1—malignant glioma	0.000137	0.000342	CbGpPWpGaD
Trimethoprim—DHFR—Disease—MDM2—malignant glioma	0.000134	0.000336	CbGpPWpGaD
Trimethoprim—DHFR—Disease—RAF1—malignant glioma	0.000134	0.000335	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000133	0.000334	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CYP2B6—malignant glioma	0.000133	0.000333	CbGpPWpGaD
Trimethoprim—DHFR—Disease—ERBB2—malignant glioma	0.000132	0.000331	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—TP53—malignant glioma	0.000131	0.000328	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PIK3CB—malignant glioma	0.000131	0.000327	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PTGS2—malignant glioma	0.00013	0.000324	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PIK3CD—malignant glioma	0.000126	0.000314	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PIK3CG—malignant glioma	0.000125	0.000312	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.000124	0.000309	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—IDH2—malignant glioma	0.000123	0.000308	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—IDH1—malignant glioma	0.000122	0.000304	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PPARG—malignant glioma	0.00012	0.000301	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—COX8A—malignant glioma	0.000118	0.000295	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—SPHK1—malignant glioma	0.000118	0.000294	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CYP2B6—malignant glioma	0.000116	0.00029	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CYP2C18—malignant glioma	0.000115	0.000288	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—IDH2—malignant glioma	0.000115	0.000288	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.000114	0.000284	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PTEN—malignant glioma	0.000113	0.000282	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.000111	0.000278	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PIK3CD—malignant glioma	0.00011	0.000274	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PIK3CB—malignant glioma	0.000109	0.000274	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000109	0.000272	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000109	0.000272	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PTGS2—malignant glioma	0.000108	0.000271	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CYP2B6—malignant glioma	0.000108	0.000271	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—IDH1—malignant glioma	0.000106	0.000265	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.000106	0.000265	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.000105	0.000263	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—SPHK1—malignant glioma	0.000103	0.000257	CbGpPWpGaD
Trimethoprim—DHFR—Disease—STAT3—malignant glioma	0.000101	0.000252	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CYP2C18—malignant glioma	0.000101	0.000251	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ASMT—malignant glioma	0.0001	0.000251	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	9.91e-05	0.000248	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—IDH1—malignant glioma	9.91e-05	0.000248	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	9.66e-05	0.000241	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—SPHK1—malignant glioma	9.59e-05	0.00024	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	9.57e-05	0.000239	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PIK3CB—malignant glioma	9.55e-05	0.000239	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PTGS2—malignant glioma	9.46e-05	0.000237	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PTEN—malignant glioma	9.46e-05	0.000236	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—BCAN—malignant glioma	9.43e-05	0.000236	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CYP2C18—malignant glioma	9.39e-05	0.000235	CbGpPWpGaD
Trimethoprim—DHFR—Disease—MYC—malignant glioma	9.39e-05	0.000235	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	9.35e-05	0.000234	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—GSTT1—malignant glioma	9.33e-05	0.000233	CbGpPWpGaD
Trimethoprim—DHFR—Disease—EGFR—malignant glioma	9.18e-05	0.000229	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	8.86e-05	0.000221	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PTGS1—malignant glioma	8.75e-05	0.000219	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	8.71e-05	0.000218	CbGpPWpGaD
Trimethoprim—DHFR—Disease—KRAS—malignant glioma	8.67e-05	0.000217	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PTEN—malignant glioma	8.25e-05	0.000206	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—GSTT1—malignant glioma	8.13e-05	0.000203	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—BCHE—malignant glioma	8.13e-05	0.000203	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	8.07e-05	0.000202	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—SLC5A5—malignant glioma	8.03e-05	0.000201	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PIK3CA—malignant glioma	7.97e-05	0.000199	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	7.89e-05	0.000197	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	7.79e-05	0.000195	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PTGS1—malignant glioma	7.62e-05	0.00019	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—IDH2—malignant glioma	7.6e-05	0.00019	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—GSTT1—malignant glioma	7.6e-05	0.00019	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	7.6e-05	0.00019	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	7.53e-05	0.000188	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CYP2B6—malignant glioma	7.14e-05	0.000179	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PTGS1—malignant glioma	7.12e-05	0.000178	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	7.09e-05	0.000177	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—BCHE—malignant glioma	7.08e-05	0.000177	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—SLC5A5—malignant glioma	7e-05	0.000175	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PIK3CA—malignant glioma	6.67e-05	0.000167	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—BCHE—malignant glioma	6.62e-05	0.000165	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	6.56e-05	0.000164	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—SLC5A5—malignant glioma	6.54e-05	0.000163	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—IDH1—malignant glioma	6.53e-05	0.000163	CbGpPWpGaD
Trimethoprim—DHFR—Disease—AKT1—malignant glioma	6.51e-05	0.000163	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—GSTP1—malignant glioma	6.47e-05	0.000162	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	6.44e-05	0.000161	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—SPHK1—malignant glioma	6.32e-05	0.000158	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CAT—malignant glioma	6.3e-05	0.000157	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CYP2C18—malignant glioma	6.19e-05	0.000155	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	6.18e-05	0.000155	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	6.13e-05	0.000153	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—NCOR1—malignant glioma	5.95e-05	0.000149	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PIK3CA—malignant glioma	5.82e-05	0.000146	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—GSTP1—malignant glioma	5.64e-05	0.000141	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CAT—malignant glioma	5.48e-05	0.000137	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—AKT1—malignant glioma	5.45e-05	0.000136	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	5.34e-05	0.000134	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—GSTP1—malignant glioma	5.27e-05	0.000132	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—NCOR1—malignant glioma	5.18e-05	0.000129	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CAT—malignant glioma	5.12e-05	0.000128	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GSTT1—malignant glioma	5.01e-05	0.000125	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CAV1—malignant glioma	4.85e-05	0.000121	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—NCOR1—malignant glioma	4.84e-05	0.000121	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—AKT1—malignant glioma	4.76e-05	0.000119	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PTGS1—malignant glioma	4.69e-05	0.000117	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.63e-05	0.000116	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PIK3CG—malignant glioma	4.41e-05	0.00011	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—BCHE—malignant glioma	4.36e-05	0.000109	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—SLC5A5—malignant glioma	4.31e-05	0.000108	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PPARG—malignant glioma	4.26e-05	0.000107	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CAV1—malignant glioma	4.22e-05	0.000106	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CAV1—malignant glioma	3.94e-05	9.86e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PIK3CD—malignant glioma	3.88e-05	9.7e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PIK3CG—malignant glioma	3.85e-05	9.61e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.77e-05	9.42e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PPARG—malignant glioma	3.71e-05	9.28e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PIK3CG—malignant glioma	3.59e-05	8.98e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GSTP1—malignant glioma	3.47e-05	8.68e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PPARG—malignant glioma	3.47e-05	8.67e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PIK3CB—malignant glioma	3.38e-05	8.46e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PIK3CD—malignant glioma	3.38e-05	8.45e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CAT—malignant glioma	3.38e-05	8.45e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PTGS2—malignant glioma	3.35e-05	8.38e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—NCOR1—malignant glioma	3.19e-05	7.98e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PIK3CD—malignant glioma	3.16e-05	7.9e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PIK3CB—malignant glioma	2.95e-05	7.37e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PTEN—malignant glioma	2.92e-05	7.31e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PTGS2—malignant glioma	2.92e-05	7.3e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PIK3CB—malignant glioma	2.75e-05	6.88e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PTGS2—malignant glioma	2.73e-05	6.82e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CAV1—malignant glioma	2.6e-05	6.5e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PTEN—malignant glioma	2.55e-05	6.37e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PTEN—malignant glioma	2.38e-05	5.95e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PIK3CG—malignant glioma	2.37e-05	5.92e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PPARG—malignant glioma	2.29e-05	5.72e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PIK3CD—malignant glioma	2.08e-05	5.21e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PIK3CA—malignant glioma	2.06e-05	5.15e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.82e-05	4.54e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PTGS2—malignant glioma	1.8e-05	4.5e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PIK3CA—malignant glioma	1.8e-05	4.49e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—AKT1—malignant glioma	1.68e-05	4.21e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PIK3CA—malignant glioma	1.68e-05	4.2e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PTEN—malignant glioma	1.57e-05	3.92e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—AKT1—malignant glioma	1.47e-05	3.67e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—AKT1—malignant glioma	1.37e-05	3.43e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.11e-05	2.77e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—AKT1—malignant glioma	9.04e-06	2.26e-05	CbGpPWpGaD
